Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Masafumi Nishino
Observed names:
M. NISHINO,
M. Nishino,
Masafumi NISHINO,
Nishino, Masafumi
Institution:
Iwata City Hospital
Observed institutions:
Hamamatsu University,
Hamamatsu University School of Medicine,
Iwata City Hospital,
Seirei Hamamatsu General Hospital,
Hospital Universitario Central de Asturias,
JA Shizuoka Koseiren ENSHU hospital
show all 6
OpenAlex ID:
A5016243449
Evidence that the Degree and Duration of Acid Suppression are Related to Helicobacter pylori Eradication by Triple Therapy
2007
·
Mitsushige Sugimoto
, Takahisa Furuta
, et al.
·
Helicobacter
·
152
Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy
2007
·
Naohito Shirai
, Mitsushige Sugimoto
, et al.
·
European Journal of Clinical Pharmacology
·
92
Rabeprazole 10 mg q.d.s. decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP 2 C 19 genotype
2012
·
M. Sugimoto
, N. Shirai
, et al.
·
Alimentary Pharmacology & Therapeutics
·
63
Effect ofMDR1C3435T polymorphism on cure rates ofHelicobacter pyloriinfection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation toCYP 2C19 genotypes and 23S rRNA genotypes ofH. pylori
2007
·
T. FURUTA
, M. SUGIMOTO
, et al.
·
Alimentary Pharmacology & Therapeutics
·
48
PDF
Sitafloxacin‐based third‐line rescue regimens for H elicobacter pylori infection in J apan
2013
·
Takahisa Furuta
, Mitsushige Sugimoto
, et al.
·
Journal of Gastroenterology and Hepatology
·
44
PDF
Modified allele‐specific primer–polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin
2007
·
Takahisa Furuta
, Yoshihiro Soya
, et al.
·
Journal of Gastroenterology and Hepatology
·
38
Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in Japan
2011
·
Mihoko Yamade
, Mitsushige Sugimoto
, et al.
·
Journal of Gastroenterology and Hepatology
·
37
CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole
2009
·
Takahisa Furuta
, Mitsushige Sugimoto
, et al.
·
European Journal of Clinical Pharmacology
·
35
Relationship Between Low-Dose Aspirin-Induced Gastric Mucosal Injury and Intragastric pH in Healthy Volunteers
2009
·
Masafumi Nishino
, Mitsushige Sugimoto
, et al.
·
Digestive Diseases and Sciences
·
32
Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics
2007
·
Mitsushige Sugimoto
, Takahisa Furuta
, et al.
·
Expert Opinion on Pharmacotherapy
·
30
Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in Japanese
2014
·
Mitsushige Sugimoto
, Naohito Shirai
, et al.
·
European Journal of Clinical Pharmacology
·
29
Ability of Rabeprazole to Prevent Gastric Mucosal Damage From Clopidogrel and Low Doses of Aspirin Depends on CYP2C19 Genotype
2012
·
Takahiro Uotani
, Mitsushige Sugimoto
, et al.
·
Clinical Gastroenterology and Hepatology
·
27
[13C]‐pantoprazole breath test to predict CYP2C19 phenotype and efficacy of a proton pump inhibitor, lansoprazole
2009
·
T. FURUTA
, C. KODAIRA
, et al.
·
Alimentary Pharmacology & Therapeutics
·
27
PDF
Esophageal Mucosal Injury With Low‐Dose Aspirin and Its Prevention by Rabeprazole
2009
·
Mitsushige Sugimoto
, Masafumi Nishino
, et al.
·
The Journal of Clinical Pharmacology
·
24
A case of small bowel adenocarcinoma in a patient with Crohn’s disease detected by PET/CT and double-balloon enteroscopy
2009
·
Chise Kodaira
, Satoshi Osawa
, et al.
·
World Journal of Gastroenterology
·
24
PDF
Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan
2008
·
Mitsushige Sugimoto
, Takahisa Furuta
, et al.
·
Journal of Gastroenterology
·
24
The dual therapy with 4 times daily dosing of rabeprazole and amoxicillin as the 3rd rescue regimen for eradication of H. pylori.
2010
·
Takahisa Furuta
, Mitsushige Sugimoto
, et al.
·
PubMed
·
23
Influence of low-dose proton pump inhibitors administered concomitantly or separately on the anti-platelet function of clopidogrel
2016
·
Takahisa Furuta
, Mitsushige Sugimoto
, et al.
·
Journal of Thrombosis and Thrombolysis
·
20
Impact of Acid Inhibition on Esophageal Mucosal Injury Induced by Low-Dose Aspirin
2011
·
Mitsushige Sugimoto
, Masafumi Nishino
, et al.
·
Digestion
·
20
Effect of MDR1 C3435T polymorphism on lansoprazole in healthy Japanese subjects
2009
·
Chise Kodaira
, Mitsushige Sugimoto
, et al.
·
European Journal of Clinical Pharmacology
·
20
Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapy
2011
·
Mitsushige Sugimoto
, Masafumi Nishino
, et al.
·
World Journal of Gastroenterology
·
19
PDF
Preventive Effects of Lansoprazole and Famotidine on Gastric Mucosal Injury Induced by Low‐Dose Aspirin inHelicobacter pylori—Negative Healthy Volunteers
2010
·
Masafumi Nishino
, Mitsushige Sugimoto
, et al.
·
The Journal of Clinical Pharmacology
·
19
MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese
2008
·
Mitsushige Sugimoto
, Takahisa Furuta
, et al.
·
Life Sciences
·
16
Improvement of gastroesophageal reflux disease in Japanese patients with spinal kyphotic deformity who underwent surgical spinal correction
2015
·
Mitsushige Sugimoto
, Tomohiko Hasegawa
, et al.
·
Digestive Endoscopy
·
14
Antiplatelet Drugs Are a Risk Factor for Esophageal Mucosal Injury
2013
·
Mitsushige Sugimoto
, Takahiro Uotani
, et al.
·
Digestion
·
14
Show more works
View as search
Works count:
76
Citation count:
989
H-index:
20
I10-index:
28
Year
Topic
Type
